Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism

Bariatric surgery developed in the late 1970 to treat severe hyperlipidemias in overweight individuals, not necessarily obese. Several techniques have been developed, and the concept has come first of a surgery for morbid obesity, then of a cure for diabetes in morbid obesity. There are other aspect...

Full description

Bibliographic Details
Main Authors: A. E. Pontiroli, A. Benetti, L. Folini, C. Merlotti, F. Frigè
Format: Article
Language:English
Published: Arán Ediciones, S. L. 2013-01-01
Series:Nutrición Hospitalaria
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112013000800015&lng=en&tlng=en
id doaj-60cf61163d9b4bd4860a7d013ea46ace
record_format Article
spelling doaj-60cf61163d9b4bd4860a7d013ea46ace2020-11-24T21:19:27ZengArán Ediciones, S. L.Nutrición Hospitalaria0212-16112013-01-0128suppl 2104108S0212-16112013000800015Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolismA. E. Pontiroli0A. Benetti1L. Folini2C. Merlotti3F. Frigè4Università degli Studi di MilanoUniversità degli Studi di MilanoUniversità degli Studi di MilanoUniversità degli Studi di MilanoUniversità degli Studi di MilanoBariatric surgery developed in the late 1970 to treat severe hyperlipidemias in overweight individuals, not necessarily obese. Several techniques have been developed, and the concept has come first of a surgery for morbid obesity, then of a cure for diabetes in morbid obesity. There are other aspects of bariatric surgery that deserve attention, beyond BMI and diabetes, such as hypertension, poor life expectancy, increased prevalence of cancer, congestive heart failure, social inadequacy. The aim of this presentation is to review some recent development in clinical research, in the fields of liver steatosis, ferritin metabolism, and cholesterol metabolism. Liver steatosis, also called fatty liver encompasses a graduation of diseases with different clinical relevance and prognosis. NAFLD correlates with atherosclerosis, insulin resistance and diabetes mellitus. There is now evidence that weight loss, obtained through diet or restrictive surgery, reduces the prevalence (and the severity) of NAFLD. An other issue is represented by serum ferritin concentrations, that are strongly associated with fibrosis, portal and lobular inflammation in NAFLD patients, especially in the presence of obesity. Body iron contributes to excess oxidative stress already at non iron overload concentrations. Moreover, serum ferritin is an important and independent predictor of the development of diabetes. Weight loss is accompanied by reduction of ferritin, more after restrictive than malabsorptive surgery. Metabolic changes are greater after malabsorptive or mixed surgery than after purely restrictive surgery, and this has been ascribed to a greater weight loss. Studies comparing the two kinds of surgery indicate that, for the same amount of weight loss, decrease of cholesterol is greater with the former than with the latter techniques, and this difference is mainly due to a greater reduction of intestinal absorption of cholesterol. In the choice of surgery for the single patient, among other aspects, malabsorptive surgery seems to be more indicated in subjects with hyperlipidemia, especially with high cholesterol levels.http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112013000800015&lng=en&tlng=enCirugía bariátricaEsteatosis hepáticaFerritinaMetabolismo colesterol
collection DOAJ
language English
format Article
sources DOAJ
author A. E. Pontiroli
A. Benetti
L. Folini
C. Merlotti
F. Frigè
spellingShingle A. E. Pontiroli
A. Benetti
L. Folini
C. Merlotti
F. Frigè
Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism
Nutrición Hospitalaria
Cirugía bariátrica
Esteatosis hepática
Ferritina
Metabolismo colesterol
author_facet A. E. Pontiroli
A. Benetti
L. Folini
C. Merlotti
F. Frigè
author_sort A. E. Pontiroli
title Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism
title_short Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism
title_full Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism
title_fullStr Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism
title_full_unstemmed Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism
title_sort other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism
publisher Arán Ediciones, S. L.
series Nutrición Hospitalaria
issn 0212-1611
publishDate 2013-01-01
description Bariatric surgery developed in the late 1970 to treat severe hyperlipidemias in overweight individuals, not necessarily obese. Several techniques have been developed, and the concept has come first of a surgery for morbid obesity, then of a cure for diabetes in morbid obesity. There are other aspects of bariatric surgery that deserve attention, beyond BMI and diabetes, such as hypertension, poor life expectancy, increased prevalence of cancer, congestive heart failure, social inadequacy. The aim of this presentation is to review some recent development in clinical research, in the fields of liver steatosis, ferritin metabolism, and cholesterol metabolism. Liver steatosis, also called fatty liver encompasses a graduation of diseases with different clinical relevance and prognosis. NAFLD correlates with atherosclerosis, insulin resistance and diabetes mellitus. There is now evidence that weight loss, obtained through diet or restrictive surgery, reduces the prevalence (and the severity) of NAFLD. An other issue is represented by serum ferritin concentrations, that are strongly associated with fibrosis, portal and lobular inflammation in NAFLD patients, especially in the presence of obesity. Body iron contributes to excess oxidative stress already at non iron overload concentrations. Moreover, serum ferritin is an important and independent predictor of the development of diabetes. Weight loss is accompanied by reduction of ferritin, more after restrictive than malabsorptive surgery. Metabolic changes are greater after malabsorptive or mixed surgery than after purely restrictive surgery, and this has been ascribed to a greater weight loss. Studies comparing the two kinds of surgery indicate that, for the same amount of weight loss, decrease of cholesterol is greater with the former than with the latter techniques, and this difference is mainly due to a greater reduction of intestinal absorption of cholesterol. In the choice of surgery for the single patient, among other aspects, malabsorptive surgery seems to be more indicated in subjects with hyperlipidemia, especially with high cholesterol levels.
topic Cirugía bariátrica
Esteatosis hepática
Ferritina
Metabolismo colesterol
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112013000800015&lng=en&tlng=en
work_keys_str_mv AT aepontiroli otheraspectsofbariatricsurgeryliversteatosisferritinandcholesterolmetabolism
AT abenetti otheraspectsofbariatricsurgeryliversteatosisferritinandcholesterolmetabolism
AT lfolini otheraspectsofbariatricsurgeryliversteatosisferritinandcholesterolmetabolism
AT cmerlotti otheraspectsofbariatricsurgeryliversteatosisferritinandcholesterolmetabolism
AT ffrige otheraspectsofbariatricsurgeryliversteatosisferritinandcholesterolmetabolism
_version_ 1726005115185266688